Neurology® Podcast

Dr. Justin Abbatemarco talks with Drs. Claire J. Creutzfeldt and Robert G. Holloway about the concept of medical forecasting, its importance in clinical practice, and the skills necessary for effective prognostication. Read the related article in JAMA. Disclosures can be found at Neurology.org.

Dr. Vikram Karnik talks with Dr. Kate Wyman-Chick about distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease, the importance of early diagnosis, and the implications for clinical practice. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Bhooma Aravamuthan about the modern definition of cerebral palsy, the philosophical implications of diagnostic labels, and the need for clarity in clinical practice. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Join neurologists John Pluvinage, Andrew McKeon, Martin Tichler, Jolt Elesch, and Marius Ringelstein in a fascinating discussion on autoimmune neurology. Pluvinage dives into anti-CD320 antibodies and their clinical significance. McKeon reveals insights about paraneoplastic CAMKV autoimmune encephalitis. Tichler highlights long-term outcomes in anti-NMDAR encephalitis patients. Elesch examines mortality rates in AQP4 antibody-positive neuromyelitis optica, while Ringelstein evaluates the efficacy of Eculizumab in clinical settings. Tune in for cutting-edge insights in neurology!

Dr. Vineet Punia, a neurologist at the Cleveland Clinic specializing in anti-seizure medication research, joins to discuss the complexities surrounding acute symptomatic seizures. He highlights how the prescribing practices vary and often don’t lead to improved outcomes for patients at discharge. The conversation delves into the impact of seizure type, brain injury causes, and the role of continuous EEG monitoring. Punia emphasizes the need for personalized treatment plans and the emotional challenges caregivers face in managing these patients.

Dr. Stacey Clardy talks with Dr. Catherine Albin about the key features of educational social media posts, strategies for creating impactful content, the importance of visual appeal, and the role of community engagement in neurology education. Read the related article in Neurology: Education. Disclosures can be found at Neurology.org.

Dr. Maarten Titulaer, an Associate Professor of Neurology specializing in anti-NMDAR encephalitis, shares insights into the long-term outcomes for patients facing this challenging condition. He discusses the variability in recovery times, with some improving in six months while others may struggle for years. The conversation highlights the importance of CSF testing for accurate diagnosis and emphasizes the need for personalized rehabilitation strategies involving multidisciplinary teams. Titulaer also distinguishes this encephalitis from other neuroimmune disorders, shedding light on its unique challenges.

Dr. Elias Sotirchos, a neuroimmunologist at Johns Hopkins, discusses the complex relationship between myelitis and rheumatologic diseases. He highlights the prevalence of neuromyelitis optica spectrum disorder in inflammatory myelopathy cases and the critical role of autoantibody identification in diagnosis. The conversation also delves into the challenges of diagnosing rare neurological conditions and the importance of using advanced imaging and serological tests. Throughout, Sotirchos emphasizes the need for tailored testing strategies and clear communication among healthcare providers.

Dr. Gregg Day talks with Dr. Kathryn T. Hall about the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments. Disclosures can be found at Neurology.org.

Dr. Ahmad Nehme, a neurologist and PhD student at Oxford University, dives into the intricate world of Cerebral Amyloid Angiopathy-related Inflammation (CAA-RI) and biopsy-positive Primary Angiitis of the CNS. He explores the challenges in diagnosing these conditions, emphasizing key imaging features and clinical symptoms like headaches and cognitive impairments. The discussion highlights a study revealing significant differences in CSF analysis and imaging markers, underlining the need for personalized treatment and ongoing research in these rare neurological diseases.